BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9522631)

  • 1. [Cardiovascular risk patient--how much prevention is necessary and rational?].
    Seiler C
    Praxis (Bern 1994); 1998 Jan; 87(5):135-40, 142, 144. PubMed ID: 9522631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of primary and secondary prevention on morbidity and mortality of ischemic cardiopathy].
    Posadas-Romero C
    Arch Cardiol Mex; 2002; 72 Suppl 1():S167-70. PubMed ID: 12001839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future directions of cardiovascular risk prediction.
    Smith SC
    Am J Cardiol; 2006 Jan; 97(2A):28A-32A. PubMed ID: 16442934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease and women: applying the guidelines for risk factor management.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():5A-10A. PubMed ID: 10653924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary and secondary prevention of the acute coronary syndrome].
    Weingärtner O; Laufs U
    Hamostaseologie; 2006 May; 26(2):158-66; quiz 167-8. PubMed ID: 16676060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive Cardiology: the SHAPE of the future. A Synopsis from the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M
    Herz; 2007 Aug; 32(5):356-61. PubMed ID: 17687524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cholesterol in Kentucky--a state at high risk.
    Whayne TF; Zielke JC
    J Ky Med Assoc; 2000 Jun; 98(6):248-53. PubMed ID: 10870339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for the control of cholesterolemia in Spain].
    Villar Alvarez F; Mata López P; Plaza Pérez I; Pérez Jiménez F; Maiques Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Abadal LT; Rodríguez Artalejo F; Gil López E
    Rev Esp Salud Publica; 2000; 74(5-6):457-74. PubMed ID: 11217236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.